Ibrotamide

This classification denotes a sedative and hypnotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 09C8B34RDF. European Medicines Agency schedules Ibrotamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08095MIG. Ibrotamide generally arises in the molecular formula C7H14BRNO. The term IBROTAMIDE is an International Non-Proprietary Name or INN. IBROTAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ibrotamide under HS 29241900 and SITC 51471. As of Q4 2014, IBROTAMIDE remains the US FDA Preferred Term for this commodity. Ibrotamide bears US NLM identifiers UMLS ID C2827189 and NCI Concept Code C83773. SMILES: BRC(C(C)C)(CC)C(=O)N.